Allogeneic hematopoietic cell transplantation using fludarabine plus myeloablative busulfan and melphalan confers promising survival in high-risk hematopoietic neoplasms: a single-center retrospective analysis
Article in Hematology (January 2021)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Hematology (January 2021)
Article in Reactions Weekly (August 2019)